REMSleep Holdings, Inc. provides an update on its testing protocol for 510K clearance of its DeltaWave CPAP Mask. RemSleep has completed the testing protocol for 510K clearance and all tests have successfully passed including the Cytotoxicity and MLA tests which were the subject of past issues requiring retesting. The company previously provided an estimate of 3-6 weeks for compiling these results and has reduced that estimate to 2-4 weeks before submitting to the FDA for 510K clearance.